#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peripheral T-cell lymphoma unspecified Spinal muscular atrophy Hypereosinophilic syndrome Acute promyelocytic leukaemia Thrombocytosis Hypomagnesaemia Retinal dystrophy Fusarium infection Infertility male Prophylaxis against transplant rejection Non-Hodgkin's lymphoma refractory Pleural mesothelioma Haemophilia A with anti factor VIII Hodgkin's disease refractory Cytokine release syndrome More trials…

    Learn about Rare Diseases

    Undifferentiated sarcoma – Trials in Disease Nephrotic syndrome – Basic Information Cerebral arteriovenous malformation haemorrhagic Urea cycle disorder Chondrosarcoma metastatic – Basic Information Haemolytic uraemic syndrome – Trials in Disease Loeys-Dietz syndrome – Life with Disease Crigler-Najjar syndrome – Diagnostics Erdheim-Chester disease – Basic Information Optic glioma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gskvx000000009151 GSKVX000000034797 RIKKUNSHITO Olopatadine Clobetasol Bisacodyl Eribulin Mesylate Rbp030.2 Prs-344 Tuvusertib Aminocaproic Acid ZIRCONIUM (89ZR) GIRENTUXIMAB Radotinib Dihydrochloride Platelet Concentrate KETOROLAC TROMETAMOL Pegunigalsidase Alfa Ibuprofen Lysine Azd7798 Olaptesed Pegol Mesna More therapies…

    Learn about Your Condition

    Mucopolysaccharidosis I Latent tuberculosis Prostate cancer recurrent Uterine leiomyosarcoma Epstein-Barr virus infection Choroidal dystrophy Adrenoleukodystrophy Ligament sprain Non-small cell lung cancer Spondylolisthesis Mucous membrane pemphigoid Postoperative delirium Barrett's oesophagus Abdominal infection C3 glomerulopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Mitomycin-C with Electromotive Drug Administration before Surgery in Patients with Non-Muscle Invasive Bladder Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Mitomycin
    Spain

  • Study on Preventing Kidney Problems in Peripheral Arterial Disease Patients Using Carbon Dioxide and Iopamidol, Iomeprol, and Iopromide During Vascular Procedures

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Iomeprol
    • Iopamidol
    • Iopromide
    Austria Germany

  • Study on Budesonide and Mannitol for Treating Inflammation in Patients with Functional Dyspepsia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dyspepsia
    Investigated Drugs:
    • Budesonide
    Belgium

  • Study on Maintenance Treatment with Pembrolizumab and Pemetrexed for Stage IV Non-Small Cell Lung Cancer Patients After Initial Chemotherapy and Immunotherapy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    France

  • Study on the Effects of ELGN-2112 (Human Insulin) for Treating Intestinal Malabsorption in Preterm Infants

    Recruiting

    3 1
    Investigated Diseases:
    • Malabsorption
    Investigated Drugs:
    • Insulin Human
    Austria France Italy The Netherlands Spain Sweden

  • Study on the Safety and Effectiveness of AZD5492 Alone or with Other Treatments for Adults with Relapsed or Refractory B-Cell Blood Cancers

    Recruiting

    1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Azd5492
    Denmark France Germany Italy Spain
Previous Page
1 … 627 628 629 630 631 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!